{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Monoclonal_Antibody_14G2A",
  "nciThesaurus": {
    "casRegistry": "",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A murine monoclonal antibody directed against the ganglioside GD2 with potential antineoplastic activity. Monoclonal antibody 14G2A binds to the ganglioside GD2 and induces antibody-dependent cell mediated cytotoxicity and complement-dependent cytotoxicity against GD2-expressing tumor cells.  GD2 is overexpressed in malignant melanoma, neuroblastoma, osteosarcoma, and small cell carcinoma of the lung.",
    "fdaUniiCode": "TC4U60XS42",
    "identifier": "C2368",
    "preferredName": "Monoclonal Antibody 14G2A",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [
      "C129822",
      "C20401"
    ],
    "synonyms": [
      "14G2A",
      "14G2A, monoclonal antibody",
      "Antibody 14G2A, Monoclonal",
      "MURINE MONOCLONAL ANTI-GD2 ANTIBODY 14G2A",
      "MoAb 14G2A",
      "Monoclonal Antibody 14G2A"
    ]
  }
}